| Efficacy and safety of low-dose colchicine after myocardial infarction JC Tardif, S Kouz, DD Waters, OF Bertrand, R Diaz, AP Maggioni, FJ Pinto, ... New England journal of medicine 381 (26), 2497-2505, 2019 | 1905 | 2019 |
| Mutations in HFE2 cause iron overload in chromosome 1q–linked juvenile hemochromatosis G Papanikolaou, ME Samuels, EH Ludwig, MLE MacDonald, ... Nature genetics 36 (1), 77-82, 2004 | 1221 | 2004 |
| Loss‐of‐function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations YP Goldberg, J MacFarlane, ML MacDonald, J Thompson, MP Dube, ... Clinical genetics 71 (4), 311-319, 2007 | 555 | 2007 |
| Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy J Robitaille, MLE MacDonald, A Kaykas, LC Sheldahl, J Zeisler, MP Dubé, ... Nature genetics 32 (2), 326-330, 2002 | 525 | 2002 |
| Exome-wide association study of plasma lipids in> 300,000 individuals DJ Liu, GM Peloso, H Yu, AS Butterworth, X Wang, A Mahajan, ... Nature genetics 49 (12), 1758-1766, 2017 | 518 | 2017 |
| Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers SA Narod, MP Dubé, J Klijn, J Lubinski, HT Lynch, P Ghadirian, ... Journal of the National Cancer Institute 94 (23), 1773-1779, 2002 | 470 | 2002 |
| Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children H Visscher, CJD Ross, SR Rassekh, A Barhdadi, MP Dubé, H Al-Saloos, ... Journal of clinical oncology 30 (13), 1422-1428, 2012 | 418 | 2012 |
| De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia J Gauthier, N Champagne, RG Lafrenière, L Xiong, D Spiegelman, ... Proceedings of the National Academy of Sciences 107 (17), 7863-7868, 2010 | 416 | 2010 |
| A dominant-negative mutation in the TRESK potassium channel is linked to familial migraine with aura RG Lafrenière, MZ Cader, JF Poulin, I Andres-Enguix, M Simoneau, ... Nature medicine 16 (10), 1157-1160, 2010 | 404 | 2010 |
| Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease CECI Infarction Genetics Myocardial The New England journal of medicine 374 (12), 1134, 2016 | 378* | 2016 |
| Coding variation in ANGPTL4, LPL, and SVEP1 and the risk of coronary disease New England journal of Medicine, 2016 | 378 | 2016 |
| Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy CJD Ross, H Katzov-Eckert, MP Dubé, B Brooks, SR Rassekh, ... Nature genetics 41 (12), 1345-1349, 2009 | 354 | 2009 |
| DNMT3A and TET2 dominate clonal hematopoiesis and demonstrate benign phenotypes and different genetic predispositions M Buscarlet, S Provost, YF Zada, A Barhdadi, V Bourgoin, G Lépine, ... Blood, The Journal of the American Society of Hematology 130 (6), 753-762, 2017 | 325 | 2017 |
| Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity V Turcot, Y Lu, HM Highland, C Schurmann, AE Justice, RS Fine, ... Nature genetics 50 (1), 26-41, 2018 | 305 | 2018 |
| Direct measure of the de novo mutation rate in autism and schizophrenia cohorts P Awadalla, J Gauthier, RA Myers, F Casals, FF Hamdan, AR Griffing, ... The American Journal of Human Genetics 87 (3), 316-324, 2010 | 287 | 2010 |
| The genetics of congenital amusia (tone deafness): a family-aggregation study I Peretz, S Cummings, MP Dubé The American Journal of Human Genetics 81 (3), 582-588, 2007 | 284 | 2007 |
| Lipoprotein (a) levels, genotype, and incident aortic valve stenosis: a prospective Mendelian randomization study and replication in a case–control cohort BJ Arsenault, SM Boekholdt, MP Dubé, É Rhéaume, NJ Wareham, ... Circulation: Cardiovascular Genetics 7 (3), 304-310, 2014 | 273 | 2014 |
| Common genetic vulnerability to depressive symptoms and coronary artery disease: a review and development of candidate genes related to inflammation and serotonin JM McCaffery, N Frasure-Smith, MP Dubé, P Théroux, GA Rouleau, ... Psychosomatic medicine 68 (2), 187-200, 2006 | 270 | 2006 |
| Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial JC Tardif, N Bouabdallaoui, PL L'allier, D Gaudet, B Shah, MH Pillinger, ... The Lancet Respiratory Medicine 9 (8), 924-932, 2021 | 264 | 2021 |
| Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins I Postmus, S Trompet, HA Deshmukh, MR Barnes, X Li, HR Warren, ... Nature communications 5 (1), 5068, 2014 | 261 | 2014 |
Michael HaydenKillam Professor, University of British ColumbiaVerified email at cmmt.ubc.ca
